Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | 27,575 | 1,280 | -29,384 |
| Depreciation Amortization | 3,651 | 2,587 | 1,537 |
| Accounts receivable | N/A | -650 | -175 |
| Accounts payable and accrued liabilities | N/A | -597 | -197 |
| Other Working Capital | -7,848 | -5,886 | -5,519 |
| Other Operating Activity | -58,581 | -23,710 | 13,710 |
| Operating Cash Flow | $-35,203 | $-26,976 | $-20,028 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | N/A | 32,108 | 25,100 |
| PPE Investments | -2,536 | -2,001 | -1,398 |
| Other Investing Activity | 18,127 | 0 | 0 |
| Investing Cash Flow | $15,591 | $30,107 | $23,702 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | N/A | -131 | -103 |
| Common Stock Issued | N/A | 975 | 882 |
| Other Financing Activity | 25,237 | 65 | 78 |
| Financing Cash Flow | $25,237 | $909 | $857 |
| Exchange Rate Effect | 0 | -7 | 2 |
| Beginning Cash Position | 8,830 | 8,830 | 8,830 |
| End Cash Position | 14,455 | 12,863 | 13,363 |
| Net Cash Flow | $5,625 | $4,033 | $4,533 |
| Free Cash Flow | |||
| Operating Cash Flow | -35,203 | -26,976 | -20,028 |
| Capital Expenditure | N/A | -2,001 | -1,398 |
| Free Cash Flow | -35,203 | -28,977 | -21,426 |